Business Context and Reporting Period
Company: Matinas Biopharma Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 14, 2021
Reporting Period: Event date January 14, 2021
Business Context: The filing discloses the Company's intent to use a slide presentation (Exhibit 99.1) at a conference held on January 14, 2021, and at subsequent investor meetings. This disclosure is made under Item 7.01 (Regulation FD Disclosure).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of a presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial position or operations are reported in this document. The filing is procedural, relating to the dissemination of information via a slide deck.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the attached slide presentation for investor communications.
Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information in this report, including the slide presentation, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. It is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the slide presentation attached as Exhibit 99.1 for any forward-looking statements or data not included in this summary.
- Confirm that the presentation is not legally "filed" with the SEC and therefore does not carry the same liability protections as a formal 10-K or 10-Q.
- Review the Company's most recent 10-K or 10-Q for actual financial metrics, as this 8-K contains none.